- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 515/10 - Spiro-condensed systems
Patent holdings for IPC class C07D 515/10
Total number of patents in this class: 33
10-year publication summary
|
4
|
1
|
1
|
2
|
3
|
3
|
5
|
3
|
1
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Pfizer Inc. | 3366 |
4 |
| Prelude Therapeutics, Incorporated | 142 |
4 |
| Janssen Pharmaceutica N.V. | 3233 |
3 |
| Jazz Pharmaceuticals Ireland Limited | 166 |
3 |
| F. Hoffmann-La Roche AG | 7835 |
2 |
| Hoffmann-La Roche Inc. | 3686 |
2 |
| Amgen Inc. | 4348 |
2 |
| Daiichi Sankyo Company, Limited | 1887 |
2 |
| Kyoto Pharmaceutical Industries, Ltd. | 21 |
2 |
| Teijin Limited | 1265 |
2 |
| Janssen Sciences Ireland UC | 167 |
1 |
| Peking University | 1416 |
1 |
| Schering Corporation | 373 |
1 |
| Sanofi | 4237 |
1 |
| Wigen Biomedicine Technology (Shanghai) Co., Ltd. | 130 |
1 |
| Merck Sharp & Dohme LLC | 3715 |
1 |
| Nodus Oncology Limited | 3 |
1 |
| Other owners | 0 |